De Novo Ventures II Overview
De Novo Ventures II General Information
Description
De Novo Ventures II was a 2003 vintage early stage venture capital fund managed by De Novo Ventures. The fund was located in Saratoga, California and invested in the Northwest, Southwest and California. The fund targeted healthcare devices & supplies, pharmaceuticals & biotechnology and life sciences sectors.
Contact Information
Fund Manager's Location
- Post Office Box 2160
- Saratoga, CA 95070
- United States
De Novo Ventures II Investments (66)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Avedro | 08-May-2009 | Pharmaceuticals | Profitable | |||
iScience Interventional | 23-Apr-2009 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
Talima Therapeutics | 31-Mar-2009 | Drug Delivery | Startup | |||
SynergEyes | 09-Feb-2009 | Therapeutic Devices | Generating Revenue | |||
Alcon and Wavetec Vision Systems | 02-Feb-2009 | Surgical Devices | Generating Revenue | |||
OncoMed Pharmaceuticals | 30-Jan-2009 | Drug Discovery | Generating Revenue | |||
Pacira CryoTech | 13-Oct-2008 | Therapeutic Devices | Profitable | |||
Bayhill Therapeutics | 02-Oct-2008 | Biotechnology | Generating Revenue | |||
EBR Systems | 28-Jul-2008 | Later Stage VC (Series C) | Therapeutic Devices | Generating Revenue | ||
Astute Medical | 01-May-2008 | Early Stage VC (Series A) | Biotechnology | Product Development |
De Novo Ventures II Investment Strategy
De Novo Ventures II Limited Partners (10)
Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
---|---|---|---|---|---|
Centurylink Defined Benefit Master Trust | Current | 15-Mar-2004 | Original | ||
Goldman Sachs Asset Management | Current | 15-Mar-2004 | Original | ||
Hod Foundation | Current | 15-Mar-2004 | Original | ||
Invesco | Current | 15-Mar-2004 | Original | ||
Knightsbridge Advisers | Fund of Funds | Current | 15-Mar-2004 | Original |
De Novo Ventures II Team (1)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Richard Ferrari | Co-Founder, Executive Chairman & Managing Director | Saratoga, CA |
De Novo Ventures II Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
De Novo Ventures II Returns History
Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
---|
De Novo Ventures II Benchmark (17)
Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
---|---|---|---|---|---|
ComVentures VI | |||||
ARCH Venture Fund VI | 31-Mar-2024 | ||||
Forward Ventures IV | 31-Dec-2021 | ||||
Lighthouse Capital Partners V | 31-Dec-2023 | ||||
HarbourVest Partners VII-Venture | 30-Jun-2024 | ||||
SV Life Sciences Fund III | 31-Dec-2022 | ||||
Quaker BioVentures I | 30-Sep-2023 | ||||
Tenaya Capital IV | 30-Sep-2023 | ||||
De Novo Ventures II | 30-Jun-2023 | ||||
Globespan Capital Partners IV | 30-Jun-2023 |
De Novo Ventures II FAQs
-
What is De Novo Ventures II?
De Novo Ventures II was a 2003 vintage early stage venture capital fund managed by De Novo Ventures.
-
Who manages De Novo Ventures II?
De Novo Ventures II is managed by De Novo Ventures.
-
Where is De Novo Ventures II domiciled?
De Novo Ventures II is domiciled in United States: Delaware.
-
What is De Novo Ventures II's size?
De Novo Ventures II has a size of
. -
What type of fund is De Novo Ventures II?
The fund type of De Novo Ventures II is Venture.
-
What is the status of De Novo Ventures II?
De Novo Ventures II is liquidated.
-
What has De Novo Ventures II invested in?
De Novo Ventures II has made numerous investments in companies like Avedro, iScience Interventional, and Talima Therapeutics within the Pharmaceuticals, Pharmaceuticals and Biotechnology, and Drug Delivery industries.
-
What has De Novo Ventures II invested in recently?
De Novo Ventures II's latest investment was on 08-May-2009 in Avedro, a company within the Pharmaceuticals industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »